Literature DB >> 22970037

Mesenchymal stem cell-like cells in classic renal angiomyolipoma.

Xinlong Yan1, Lixin Shi, Guangfu Chen, Xu Zhang, Bing Liu, Wen Yue, Xuetao Pei, Shengkun Sun.   

Abstract

As a benign mesenchymal tumor, classic renal angiomyolipoma (AML) may obliterate the kidney parenchyma and cause renal hemorrhage. It has previously been reported that mesenchymal stem cells (MSCs) are involved in tumorigenesis; however, there have been no studies on stem cells with renal AML origin. In the present study, six females with classic renal AML received a partial or total nephrectomy. During surgery, tumor tissues were collected and culture expansion of adhesive fibroblastoid cells from these tissues was performed. We successfully isolated and cultured MSC-like cells from all six renal AML tumors. MSC characteristics, including morphology, immunophenotype and multidifferentiation potential were analyzed. Flow cytometry analysis revealed that these cells are highly similar to human bone marrow MSCs due to the expression of MSC-specific surface proteins, including CD29, CD44, CD73, CD90 and CD105. The stem cell-like nature of these cells is further supported by their adipogenic and osteogenic differentiation potentials when incubated in appropriate differentiation cocktails. Renal AML-derived adhesive cells possessing the characteristics of MSCs are described for the first time. They are a novel cell type which may be useful in future studies with regards to determining the role of stem cells in the formation and development of renal AML.

Entities:  

Year:  2012        PMID: 22970037      PMCID: PMC3439124          DOI: 10.3892/ol.2012.760

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  Perivascular ancestors of adult multipotent stem cells.

Authors:  Mirko Corselli; Chien-Wen Chen; Mihaela Crisan; Lorenza Lazzari; Bruno Péault
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

2.  Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts.

Authors:  Matthew D Plotkin; Michael S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2006-04-18

3.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

4.  Perivascular multipotent progenitor cells in human organs.

Authors:  Mihaela Crisan; Chien-Wen Chen; Mirko Corselli; Gabriella Andriolo; Lorenza Lazzari; Bruno Péault
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

5.  Skin carcinoma arising from donor cells in a kidney transplant recipient.

Authors:  Sélim Aractingi; Jean Kanitakis; Sylvie Euvrard; Caroline Le Danff; Isabelle Peguillet; Kiarash Khosrotehrani; Olivier Lantz; Edgardo D Carosella
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

6.  Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC).

Authors:  F Bonetti; M Pea; G Martignoni; C Doglioni; G Zamboni; P Capelli; P Rimondi; A Andrion
Journal:  Pathology       Date:  1994-07       Impact factor: 5.306

7.  Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice.

Authors:  Hanchen Li; Xueli Fan; Ramesh C Kovi; YunJu Jo; Brian Moquin; Richard Konz; Calin Stoicov; Evelyn Kurt-Jones; Steven R Grossman; Steven Lyle; Arlin B Rogers; Marshall Montrose; JeanMarie Houghton
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors.

Authors:  Patrizia Barozzi; Mario Luppi; Fabio Facchetti; Cristina Mecucci; Milena Alù; Ronit Sarid; Valeria Rasini; Luisa Ravazzini; Elisa Rossi; Silvana Festa; Barbara Crescenzi; Dana G Wolf; Thomas F Schulz; Giuseppe Torelli
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

9.  The use of the Ki-67 marker in the pathological diagnosis of the epithelioid variant of renal angiomyolipoma.

Authors:  Sue Min Ooi; Justin B Vivian; Ronald J Cohen
Journal:  Int Urol Nephrol       Date:  2008-10-07       Impact factor: 2.370

10.  Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

Authors:  Brigitte Royer-Pokora; Maike Busch; Manfred Beier; Constanze Duhme; Carmen de Torres; Jaume Mora; Artur Brandt; Hans-Dieter Royer
Journal:  Hum Mol Genet       Date:  2010-01-27       Impact factor: 6.150

View more
  3 in total

1.  Expression of CD44 and CD29 by PEComa cells suggests their possible origin of mesenchymal stem cells.

Authors:  Ruixue Liu; Wei Jia; Hong Zou; Xinhua Wang; Yan Ren; Jin Zhao; Lianghai Wang; Man Li; Yan Qi; Yaoyuan Shen; Weihua Liang; Jinfang Jiang; Zhenzhu Sun; Lijuan Pang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Renal cystic disease in tuberous sclerosis complex.

Authors:  Prashant Kumar; Fahad Zadjali; Ying Yao; John J Bissler
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-06

3.  Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target

Authors:  Oren Pleniceanu; Racheli Shukrun; Dorit Omer; Einav Vax; Itamar Kanter; Klaudyna Dziedzic; Naomi Pode-Shakked; Michal Mark-Daniei; Sara Pri-Chen; Yehudit Gnatek; Hadas Alfandary; Nira Varda-Bloom; Dekel D Bar-Lev; Naomi Bollag; Rachel Shtainfeld; Leah Armon; Achia Urbach; Tomer Kalisky; Arnon Nagler; Orit Harari-Steinberg; Jack L Arbiser; Benjamin Dekel
Journal:  EMBO Mol Med       Date:  2017-04       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.